Related Experiment Video
Updated: Jul 3, 2025
09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.9K
[Respiratory syncytial virus vaccines]
Quentin Le Hingrat1, Donia Bouzid2
1Université Paris Cité, Inserm, centre de recherche Infection, antimicrobiens, modélisation, évolution (IAME), Paris, France. Service de virologie, AP-HP, hôpital Bichat-Claude-Bernard, Paris, France.
La Revue Du Praticien
|February 14, 2024
Summary
New vaccines for respiratory syncytial virus (RSV) are in development to protect infants and older adults from severe respiratory infections. These advanced RSV vaccines target vulnerable populations, offering promising prevention strategies.
Area of Science:
- Virology
- Immunology
- Vaccinology
Context:
- Respiratory syncytial virus (RSV) causes significant lower respiratory tract infections, especially in infants under five and adults over 60.
- Current preventive measures include monoclonal antibodies like palivizumab and nirsevimab for bronchiolitis.
- High-risk populations include young children and the elderly, necessitating effective prophylactic interventions.
Purpose:
- To review the landscape of respiratory syncytial virus (RSV) vaccines currently under development.
- To outline the different vaccine platforms being investigated for RSV prevention.
- To identify the target populations for new RSV vaccines.
Summary:
- Four primary vaccine types are in development: subunit, mRNA, recombinant vector, and live-attenuated vaccines.
- These vaccines utilize recombinant proteins, viral pseudoparticles, or genetic material (mRNA) for immunization.
- Vaccine candidates aim to elicit protective immune responses against RSV infection.
Impact:
- Potential to significantly reduce the burden of RSV-related lower respiratory infections in infants and the elderly.
- Development of novel vaccination strategies for vulnerable populations, including pregnant women for passive infant immunity.
- Advancement in vaccinology offering new tools for controlling a major global respiratory pathogen.
Keywords:
Bronchiolitis ObliteransMore Related Videos
Related Concept Videos
01:31Common Respiratory Disorders
514
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
514
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:21Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228
01:16Drugs Used in Upper Respiratory Disorders: Overview
248
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
248
01:21Acute Respiratory Failure-I
208
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
208
01:29Acute Respiratory Failure-V
139
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
139